291 related articles for article (PubMed ID: 16982764)
21. Penta-O-galloyl-beta-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression.
Kuo PT; Lin TP; Liu LC; Huang CH; Lin JK; Kao JY; Way TD
J Agric Food Chem; 2009 Apr; 57(8):3331-9. PubMed ID: 19320436
[TBL] [Abstract][Full Text] [Related]
22. Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells.
Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Kin Y; Fuller GN; Lakka SS; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Yung WK; Rao JS
Clin Cancer Res; 2001 Aug; 7(8):2519-26. PubMed ID: 11489835
[TBL] [Abstract][Full Text] [Related]
23. Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model.
Cheng L; Zhang S; Sweeney CJ; Kao C; Gardner TA; Eble JN
Anticancer Res; 2004; 24(4):2135-40. PubMed ID: 15330153
[TBL] [Abstract][Full Text] [Related]
24. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice.
Aharinejad S; Paulus P; Sioud M; Hofmann M; Zins K; Schäfer R; Stanley ER; Abraham D
Cancer Res; 2004 Aug; 64(15):5378-84. PubMed ID: 15289345
[TBL] [Abstract][Full Text] [Related]
25. [Effects of anti-gene and antisense therapeutics on human prostate cancer xenograft in nude mice].
Zhang Y; Ma Y; Lu HP; Zhou XF; Xie Y; Gao JH; Liang CS
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2073-6. PubMed ID: 19080439
[TBL] [Abstract][Full Text] [Related]
26. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
Narla G; DiFeo A; Yao S; Banno A; Hod E; Reeves HL; Qiao RF; Camacho-Vanegas O; Levine A; Kirschenbaum A; Chan AM; Friedman SL; Martignetti JA
Cancer Res; 2005 Jul; 65(13):5761-8. PubMed ID: 15994951
[TBL] [Abstract][Full Text] [Related]
27. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
[TBL] [Abstract][Full Text] [Related]
28. Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.
Soff GA; Sanderowitz J; Gately S; Verrusio E; Weiss I; Brem S; Kwaan HC
J Clin Invest; 1995 Dec; 96(6):2593-600. PubMed ID: 8675623
[TBL] [Abstract][Full Text] [Related]
29. The crucial role of cyclooxygenase-2 in osteopontin-induced protein kinase C alpha/c-Src/IkappaB kinase alpha/beta-dependent prostate tumor progression and angiogenesis.
Jain S; Chakraborty G; Kundu GC
Cancer Res; 2006 Jul; 66(13):6638-48. PubMed ID: 16818637
[TBL] [Abstract][Full Text] [Related]
30. Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway.
Zins K; Abraham D; Sioud M; Aharinejad S
Cancer Res; 2007 Feb; 67(3):1038-45. PubMed ID: 17283136
[TBL] [Abstract][Full Text] [Related]
31. Molecular basis for the involvement of thymidine phosphorylase in cancer invasion.
Gotanda T; Haraguchi M; Tachiwada T; Shinkura R; Koriyama C; Akiba S; Kawahara M; Nishiyama K; Sumizawa T; Furukawa T; Mimata H; Nomura Y; Akiyama S; Nakagawa M
Int J Mol Med; 2006 Jun; 17(6):1085-91. PubMed ID: 16685420
[TBL] [Abstract][Full Text] [Related]
32. Enhanced in vitro invasiveness of ovarian cancer cells through up-regulation of VEGF and induction of MMP-2.
Zhang A; Meng L; Wang Q; Xi L; Chen G; Wang S; Zhou J; Lu Y; Ma D
Oncol Rep; 2006 Apr; 15(4):831-6. PubMed ID: 16525667
[TBL] [Abstract][Full Text] [Related]
33. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
Quemener C; Gabison EE; Naïmi B; Lescaille G; Bougatef F; Podgorniak MP; Labarchède G; Lebbé C; Calvo F; Menashi S; Mourah S
Cancer Res; 2007 Jan; 67(1):9-15. PubMed ID: 17210677
[TBL] [Abstract][Full Text] [Related]
34. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
[TBL] [Abstract][Full Text] [Related]
35. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
[TBL] [Abstract][Full Text] [Related]
36. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
37. Antisense MBD2 gene therapy inhibits tumorigenesis.
Slack A; Bovenzi V; Bigey P; Ivanov MA; Ramchandani S; Bhattacharya S; tenOever B; Lamrihi B; Scherman D; Szyf M
J Gene Med; 2002; 4(4):381-9. PubMed ID: 12124980
[TBL] [Abstract][Full Text] [Related]
38. Co-inoculation of prostate cancer cells with U937 enhances tumor growth and angiogenesis in vivo.
Craig M; Ying C; Loberg RD
J Cell Biochem; 2008 Jan; 103(1):1-8. PubMed ID: 17541941
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the invasion-metastasis mechanism in pancreatic cancer: involvement of plasmin(ogen) cascade proteins in the invasion of pancreatic cancer cells.
Tan X; Egami H; Nozawa F; Abe M; Baba H
Int J Oncol; 2006 Feb; 28(2):369-74. PubMed ID: 16391791
[TBL] [Abstract][Full Text] [Related]
40. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo.
Bendrik C; Robertson J; Gauldie J; Dabrosin C
Cancer Res; 2008 May; 68(9):3405-12. PubMed ID: 18451168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
